06.03.2023 SHOP APOTHEKE EUROPE N.V.  NL0012044747

EQS-News: CEO Stefan Feltens to Retire from SHOP APOTHEKE EUROPE.


 

EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Personnel
CEO Stefan Feltens to Retire from SHOP APOTHEKE EUROPE.

06.03.2023 / 18:17 CET/CEST
The issuer is solely responsible for the content of this announcement.


CEO Stefan Feltens to Retire from SHOP APOTHEKE EUROPE.

Sevenum, 6 March 2023. SHOP APOTHEKE EUROPE’s CEO, Stefan Feltens, has informed Björn Söder, chairman of the Supervisory Board that for purely personal reasons, he will not be available for another term after the expiration of his current 4-year term on 26 April 2023 when the company’s Annual General Meeting will be held.

Since Stefan Feltens joined SHOP APOTHEKE EUROPE in September 2018, he contributed to the company’s amazing growth story – from around 3 million customers or half a billion euros in sales four years ago to 9.3 million customers and sales of more than 1.2 billion euros this year. Throughout this period of time, SHOP APOTHEKE EUROPE has continued to enhance its customer value proposition; internal structures and processes have been established or improved to prepare the company for continuous growth in the future.

Stefan Feltens comments his decision: “It has been a tremendous privilege to serve SHOP APOTHEKE EUROPE over the last years. I remain fully convinced that the company is poised for a great future – in terms of attracting and serving many more customers, offering great development opportunities for its employees, but also meeting the expectations of its shareholders. Great teamwork has been the genesis of SHOP APOTHEKE EUROPE‘s success to date. In my mind there is no doubt that such teamwork will take the company to new heights in the future.”

After the company’s Annual General Meeting on 26 April, Stefan will remain with SHOP APOTHEKE EUROPE until the end of May to ensure a smooth handover of his responsibilities. Afterwards, Stefan will continue to support SHOP APOTHEK EUROPE as a special advisor on an as-needed basis.

CCO, Deputy CEO and co-founder of SHOP APOTHEKE EUROPE Stephan Weber: “In the last four years, Stefan has managed to  professionalise the company significantly in all relevant areas. Thanks to him our company’s structures, processes and strategy are firmly in place to continue our success story with further growth in Europe. Moreover, we thank Stefan for the super exciting time together and for the many things we learned from him on a professional and personal level. We all wish him only the best for the future.“

The company’s Supervisory Board, which is in charge of nominations to the Executive Management, has already initiated an external search for Stefan’s successor. From the date of the Annual General Meeting until a new CEO is on board, Stefan’s current responsibilities will be managed by his fellow members of the Managing Board.

Björn Söder, chairman of the SHOP APOTHEKE EUROPE’s Supervisory Board: "We are extremely grateful for Stefan Felten’s contribution to the success of SHOP APOTHEKE EUROPE. During his leadership, we reached many important strategic milestones while balancing strong growth with improved profitability. We are sorry to lose him, but wish him all the best for his personal future."

 

ABOUT SHOP APOTHEKE EUROPE.

SHOP APOTHEKE EUROPE is one of Europe’s leading and fastest-growing online pharmacies, currently operating in Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.


Headquartered in the Dutch logistics hub of Sevenum near Venlo with locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Lille and Eindhoven, SHOP APOTHEKE EUROPE offers its customers a broad range of more than 100,000 original products at attractive prices: OTC, beauty and personal care products as well as prescription drugs, supplemented by high quality natural food and health products, low carb products and sports nutrition. Currently, over 9 million active customers trust SHOP APOTHEKE EUROPE.


Since safe and reliable pharmaceutical advice are top priorities at SHOP APOTHEKE EUROPE, the e-pharmacy provides comprehensive pharmaceutical consulting services. In preparation for the full introduction of the electronic prescriptions in Germany, the company is continuously expanding in the area of digital health services.


SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 2016 and is part of the SDAX stock index.

 

 



06.03.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: SHOP APOTHEKE EUROPE N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: [email protected]
Internet: www.shop-apotheke-europe.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y07
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1575833

 
End of News EQS News Service

1575833  06.03.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1575833&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023
Umsatzerlöse1 283,99 539,71 701,01 968,06 1.060,32 1.204,35 1.798,76
EBITDA1,2 -12,14 -15,56 -18,58 15,20 -38,73 -29,66 39,99
EBITDA-Marge3 -4,27 -2,88 -2,65 1,57 -3,65 -2,46
EBIT1,4 -19,20 -28,73 -33,45 -0,87 -65,70 -69,17 -17,30
EBIT-Marge5 -6,76 -5,32 -4,77 -0,09 -6,20 -5,74 -0,96
Jahresüberschuss1 -21,36 -33,61 -36,27 -16,77 -74,19 -77,65 -11,61
Netto-Marge6 -7,52 -6,23 -5,17 -1,73 -7,00 -6,45 -0,65
Cashflow1,7 -23,24 -23,54 -30,37 17,80 11,64 -29,11 61,46
Ergebnis je Aktie8 -2,25 -2,79 -2,78 -1,17 -4,15 -4,32 -0,73
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Forvis Mazars

INVESTOR-INFORMATIONEN
©boersengefluester.de
Redcare Pharmacy
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A2AR94 143,000 Halten 2.908,98
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
79,44 0,00 0,00 -68,49
KBV KCV KUV EV/EBITDA
5,57 47,33 1,62 76,84
Dividende '22 in € Dividende '23 in € Div.-Rendite '23
in %
Hauptversammlung
0,00 0,00 0,00 17.04.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
25.04.2024 30.07.2024 05.11.2024 05.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
4,19% 8,04% 9,16% 17,02%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu SHOP APOTHEKE EUROPE N.V.  ISIN: NL0012044747 können Sie bei EQS abrufen


E-Commerce , A2AR94 , RDC , XETR:RDC